Free Trial
→ Why I'm selling my Snapback Indicator for just $7 (From Base Camp Trading) (Ad)tc pixel
NASDAQ:FEED

Nanovibronix Q1 2026 Earnings Results & Report

Nanovibronix logo
$0.28 -0.03 (-8.26%)
As of 11/10/2026 02:27 PM Eastern

Nanovibronix reported Q1 2026 earnings on May 18, 2026. The company reported EPS of -$82.56, while revenue was $653 thousand.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
After Market Closes

Nanovibronix EPS Results

Actual EPS
-$82.56
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Nanovibronix Revenue Results

Actual Revenue
$653 thousand
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Nanovibronix Q1 2026 Earnings FAQ

Nanovibronix (NASDAQ:FEED) reported earnings of -$82.56 per share for Q1 2026. The report was announced on Monday, May 18, 2026.

Nanovibronix reported revenue of $653 thousand for Q1 2026.

Nanovibronix Earnings Headlines

ENvue Medical Issues Letter to Shareholders
October 26, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/newswire/8451540/envue-medical-issues-letter-to-shareholders/
ENvue Medical Provides Nasdaq Listing Update
September 15, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/15/3362547/0/en/envue-medical-provides-nasdaq-listing-update.html
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
November 11 at 1:00 AM  |  Behind the Markets (Ad)
ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders
September 9, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/09/3358659/0/en/envue-medical-resumes-u-s-commercial-shipments-of-nanovibronix-painshield-and-begins-fulfilling-open-distributor-orders.html
FEED Share News Today
September 8, 2026  |  uk.investing.comhttps://uk.investing.com/equities/nanovibronix-news
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
September 2, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/02/3355138/0/en/envue-medical-selected-to-exhibit-envue-navigation-platform-at-vizient-innovative-technology-exchange.html
See More Nanovibronix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nanovibronix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nanovibronix and other key companies, straight to your email.

About Nanovibronix

Nanovibronix (NASDAQ:FEED) is a medical device company focused on developing and commercializing noninvasive therapeutic ultrasound products. Its technology is designed to deliver low-intensity ultrasound through the skin for applications involving pain management, wound care and other therapeutic needs.

The company’s product portfolio has included PainShield, a wearable ultrasound device intended to provide localized relief for chronic and acute pain, and WoundShield, a device designed to support the treatment of chronic and difficult-to-heal wounds. NanoVibronix has marketed its products through healthcare providers, distributors and direct-to-consumer channels.

NanoVibronix has operated in the United States and international markets, including through distribution relationships in Europe and other regions. Public references generally identify NanoVibronix under the ticker symbol NAOV; the symbol FEED does not appear to correspond to the company.

View Nanovibronix Profile
Earnings Tools